GILUPI Nanomedizin Product Pipeline Analysis, 2017 Update [Updated: 18052017] Prices from USD $750

01:30 EDT 16 Jun 2017 | BioPortfolio Report Blog


GILUPI Nanomedizin GILUPI is a medical equipment company that commercializes and develops medical devices for isolating rare cells from blood for diagnosis. The company develops medical detector that is used invivo in a patient's vein for catching rare cells such as tumor cells or fetal cells. Its products are used in the therapeutic areas of breast cancer, prostate cancer, diagnosing lung cancer, and prenatal diagnosis. GILUPI also has developed CellCollector for the in vivo isolation of circulating tumor cells. The company partners with various hospitals and medical universities. It also has operations in Cologne, Frankfurt, Munich, Berlin, Hamburg, and others. GILUPI is headquartered in Potsdam, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company GILUPI Nanomedizin
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: GILUPI Nanomedizin Product Pipeline Analysis, 2017 Update [Updated: 18052017] Prices from USD $750


More From BioPortfolio on "GILUPI Nanomedizin Product Pipeline Analysis, 2017 Update [Updated: 18052017] Prices from USD $750"

Quick Search


Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...